(Q48490624)

12 February 2018

title

Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1101283

21 August 2022

Caffeine in the Treatment of Children With Minimal Brain Dysfunction or Hyperkinetic Syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

20 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

20 September 2023

author name string

M. D. Gross

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1101283

21 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1101283

21 August 2022

publication date

1 January 1975

1 reference

12 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0033318275712306?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

https://api.elsevier.com/content/article/PII:S0033318275712306?httpAccept=text/plain

20 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

20 September 2023

1 reference

12 February 2018

volume

16

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

26-27

1 reference

12 February 2018

Caffeine as a Substitute for Schedule II Stimulants in Hyperkinetic Children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2875%2971230-6

7 January 2021

Minimal brain dysfunctions in the school-age child. Diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2875%2971230-6

7 January 2021

Psychopharmacology for the Hyperkinetic Child

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2875%2971230-6

7 January 2021

Imipramine in the Treatment of Minimal Brain Dysfunction in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2875%2971230-6

7 January 2021

Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2875%2971230-6

7 January 2021

Diagnosis and treatment of the hyperactive child

series ordinal

4

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

Childhood behavior and learning problems treated with imipramine

20 September 2023

series ordinal

7

1 reference

https://api.crossref.org/works/10.1016/S0033-3182(75)71230-6

20 September 2023

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018